Y Kihara, M Otsuki. Show Affiliations »
Abstract
Entities: Chemical
Mesh： See more » AgedAntibiotics, Antitubercular/bloodAntibiotics, Antitubercular/therapeutic useClarithromycin/therapeutic useDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/drug therapyDrug InteractionsDrug Therapy, Combination/therapeutic useEthambutol/therapeutic useGliclazide/bloodGliclazide/therapeutic useGlycated Hemoglobin A/analysisHumansHypoglycemic Agents/bloodHypoglycemic Agents/therapeutic useIsoniazid/therapeutic useMaleMycobacterium Infections, Nontuberculous/complicationsMycobacterium Infections, Nontuberculous/drug therapyNontuberculous MycobacteriaRifampin/bloodRifampin/therapeutic use
Substances： See more » Antibiotics, AntitubercularGlycated Hemoglobin AHypoglycemic AgentsEthambutolGliclazideClarithromycinIsoniazidRifampin
Year: 2000 PMID： 10937528 DOI： 10.2337/diacare.23.8.1204
Source DB: PubMed Journal: Diabetes Care ISSN： 0149-5992 Impact factor: 19.112